The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / VEXAS: A Newly Identified & Vexing Myeloid-Driven Inflammation

VEXAS: A Newly Identified & Vexing Myeloid-Driven Inflammation

December 14, 2020 • By Bryn Nelson, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A large, international team of rheumatologists, geneticists, hematologists and other researchers has discovered a severe inflammatory syndrome linked to an acquired genetic mutation in the bone marrow of older men. The X-linked syndrome, they found, is caused by a somatic mutation in myeloid stem cells that hobbles the master regulator of a pathway tasked with ridding cells of accumulated protein debris.

You Might Also Like
  • New Genetic Loci Identified, Epigenome Explored in Juvenile Idiopathic Arthritis
  • COPA Genetic Mutation Identified in Lung Disease, Arthritis
  • Newly Discovered Molecule Modulates Cartilage Repair
Explore This Issue
December 2020

They showed that the alteration of this ubiquitylation pathway by a mutation in the UBA1 gene that encodes the ubiquitin-activating (E1) enzyme results in inflamed myeloid blood cells and a variety of clinical symptoms that can masquerade as other disorders. “The overall main message is that we discovered a new disease that was hiding out amongst a variety of clinical diagnoses,” says Peter Grayson, MD, MSc, the study’s co-senior author and a tenure-track investigator at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Md. “We have theorized for a long time that somatic or acquired mutations may cause rheumatic diseases, but this is really one of the first examples of that actually being identified.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

VEXAS

In the new study, published in The New England Journal of Medicine, the researchers dubbed the syndrome VEXAS, after some of its distinguishing features (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic). Among the 25 men in the study, all had a mutation altering the E1 enzyme’s methionine-41 codon, the start site of a shorter protein isoform that regulates the debris-removal process of ubiquitylation. In VEXAS, the abnormally truncated E1 isoform is enzymatically inactive.

The mutation, Dr. Grayson says, was previously hidden in the data because it appears almost exclusively in myeloid cells and not in lymphocytes. Other genetic diseases have been linked to downstream players in the cellular cleanup process, but the group’s new finding represents one of the first known dysregulations of the master switch. In zebrafish embryos, the team showed a UBA1 gene knockout results in a similar activation of myeloid cells, bolstering the evidence that the mutation causes myeloid-driven inflammation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

‘We knew clinically about patients with systemic inflammatory disease & myelodysplasia; we just didn’t realize that there was a unifying process driving these conditions.’ —Dr. Grayson

Kenneth Warrington, MD, professor of medicine and chair of the division of rheumatology at the Mayo Clinic, Rochester, Minn., hailed the “landmark discovery” as a big step toward understanding the root cause of VEXAS and improving therapeutic interventions. “I think where there is more to be discovered is in how we end up seeing this varied clinical phenotype,” Dr. Warrington says, citing potential interactions with other genes or environmental factors as modulating influences. “It’s obviously not just one gene with one disease, but one gene with a more varied clinical syndrome, which I think, in essence, makes it more interesting and probably why it took so long to identify this.”

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Research Reviews, Systemic Inflammatory Syndromes Tagged With: genetics, Giant Cell Arteritis, myeloid cells, polyarteritis nodosa, relapsing polychondritis, VEXASIssue: December 2020

You Might Also Like:
  • New Genetic Loci Identified, Epigenome Explored in Juvenile Idiopathic Arthritis
  • COPA Genetic Mutation Identified in Lung Disease, Arthritis
  • Newly Discovered Molecule Modulates Cartilage Repair
  • Study Uncovers Tet2’s Role in Resolving Inflammation

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)